Department of Bioengineering and Therapeutic Sciences

Burchard named to expert panel for Obama’s precision medicine plan

School faculty member Esteban G. Burchard, MD, MPH, has been appointed to an expert panel advising the National Institutes of Health (NIH) on how to develop President Barack Obama’s Precision Medicine Initiative.

Update from the Dean - Spring/Summer 2015

Strategic planning; Top NIH funding; Recently received research funding (Craik, Gartner, Abate, Cole, Aweeka); Recent faculty publications (DeGrado, Ahituv, Cutler, Pon, Branch, Chuang, Huynh); Education (Youmans): UCSF Bridges Pharmacy Curriculum Project, DRIVE Team; new staff (Nguyen, Miller);...

Neely appointed BTS department manager and MSO

Dear faculty and staff,

It is my pleasure to announce the appointment of William (Bill) Neely as the department manager and MSO for the Department of Bioengineering and Therapeutic Sciences (BTS).

UCSF School of Pharmacy leads in NIH funding for 35th year in a row

For the 35th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $31.8 million during the 2014 fiscal year, from October 1, 2013 to September 30,...

Robert Gibson: alumnus, educator, advocate

School of Pharmacy alumnus Robert Gibson, PharmD '58, has been a tireless advocate for equality in education and in the profession of pharmacy, and is still active as a board member of the California Pharmacists Association Education Foundation.

It’s About A Billion Lives Symposium

Celebrating Tobacco Research and Education at UCSF

Most recent School of Pharmacy primary faculty hires, by department

The most recently hired faculty members to join the UCSF School of Pharmacy have research interests that range from the treatment of blood clots to mapping biological networks in cancer cells to understanding the molecular workings of ion channels in cell membranes. But they all share the common...

Desai Lab develops nanodevices to aid artery repair

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

Pages